Metabolic reprogramming in the tumor microenvironment of liver cancer

Jian Lin,Dongning Rao,Mao Zhang,Qiang Gao

DOI: https://doi.org/10.1186/s13045-024-01527-8

IF: 28.5

2024-02-02

Journal of Hematology & Oncology

Abstract:The liver is essential for metabolic homeostasis. The onset of liver cancer is often accompanied by dysregulated liver function, leading to metabolic rearrangements. Overwhelming evidence has illustrated that dysregulated cellular metabolism can, in turn, promote anabolic growth and tumor propagation in a hostile microenvironment. In addition to supporting continuous tumor growth and survival, disrupted metabolic process also creates obstacles for the anticancer immune response and restrains durable clinical remission following immunotherapy. In this review, we elucidate the metabolic communication between liver cancer cells and their surrounding immune cells and discuss how metabolic reprogramming of liver cancer impacts the immune microenvironment and the efficacy of anticancer immunotherapy. We also describe the crucial role of the gut–liver axis in remodeling the metabolic crosstalk of immune surveillance and escape, highlighting novel therapeutic opportunities.

oncology,hematology

What problem does this paper attempt to address?

The paper primarily explores metabolic reprogramming in the tumor microenvironment of liver cancer and its impact on the immune microenvironment. It also discusses how these metabolic changes affect the efficacy of anti-liver cancer immunotherapy. Specifically, the paper aims to address the following key issues:

1. **The role of metabolic reprogramming in the development of liver cancer**: The paper mentions that the development of liver cancer is often accompanied by liver dysfunction, leading to metabolic rearrangement. The authors point out that abnormal cellular metabolism can further promote the proliferation of liver cancer cells and the spread of the tumor.

2. **The relationship between metabolic reprogramming and the immunosuppressive microenvironment**: Metabolic changes in liver cancer cells not only support the continuous growth and survival of the tumor but may also hinder effective anti-tumor immune responses, limiting the sustained clinical remission after immunotherapy.

3. **The link between metabolic reprogramming and the efficacy of immunotherapy**: The paper elaborates on the metabolic communication between liver cancer cells and their surrounding immune cells, and how this metabolic reprogramming affects the immune microenvironment and the efficacy of anti-tumor immunotherapy.

4. **The role of the gut-liver axis**: The paper also describes the important role of the gut-liver axis in metabolic dialogue in reshaping immune surveillance and evasion, emphasizing that this provides potential opportunities for developing new therapeutic strategies.

In summary, the paper aims to reveal the interaction between liver cancer metabolism and immune metabolism, thereby providing new insights and potential targets for the diagnosis, treatment, and prognosis evaluation of liver cancer. By understanding these complex metabolic changes and their impact on the immune system, researchers hope to discover new ways to improve the efficacy of immunotherapy.